SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Therapie Psychischer Erkrankungen, 2015,

    CrossRef

  2. 2
    D. M. Taylor, V. Cornelius, L. Smith, A. H. Young, Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis, Acta Psychiatrica Scandinavica, 2014, 130, 6
  3. You have free access to this content3
    Charles L. Bowden, Expand the applicability and acceptability of CBT approaches in mood disorders, World Psychiatry, 2014, 13, 3
  4. 4
    Manish Mittal, Donald L. Harrison, Michael J. Miller, Nancy C. Brahm, National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning, Research in Social and Administrative Pharmacy, 2014, 10, 5, 781

    CrossRef

  5. 5
    Cecilio Álamo, Francisco López-Muñoz, Pilar García-García, The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder, Expert Review of Neurotherapeutics, 2014, 14, 6, 593

    CrossRef

  6. 6
    Therapie Psychischer Erkrankungen, 2014,

    CrossRef

  7. 7
    Rita Bauer, Tasha Glenn, Martin Alda, Kemal Sagduyu, Wendy Marsh, Paul Grof, Rodrigo Munoz, Greg Murray, Philipp Ritter, Ute Lewitzka, Emanuel Severus, Peter C Whybrow, Michael Bauer, Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity, International Journal of Bipolar Disorders, 2013, 1, 1, 26

    CrossRef

  8. 8
    S. Nassir Ghaemi, P. A. Vohringer, E. A. Whitham, Antidepressants from a public health perspective: re-examining effectiveness, suicide, and carcinogenicity, Acta Psychiatrica Scandinavica, 2013, 127, 2
  9. 9
    L. Tondo, R. J. Baldessarini, G. Vázquez, B. Lepri, C. Visioli, Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders, Acta Psychiatrica Scandinavica, 2013, 127, 5
  10. 10
    A. Koukopoulos, D. Reginaldi, L. Tondo, C. Visioli, R.J. Baldessarini, Course sequences in bipolar disorder: Depressions preceding or following manias or hypomanias, Journal of Affective Disorders, 2013, 151, 1, 105

    CrossRef

  11. 11
    Emanuela Offidani, Giovanni A. Fava, Elena Tomba, Ross J. Baldessarini, Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review, Psychotherapy and Psychosomatics, 2013, 82, 3, 132

    CrossRef

  12. 12
    Boghos I Yerevanian, Young Mee Choi, Impact of psychotropic drugs on suicide and suicidal behaviors, Bipolar Disorders, 2013, 15, 5
  13. 13
    Carol Paton, Roma Adroer, Thomas RE Barnes, Monitoring lithium therapy: the impact of a quality improvement programme in the UK, Bipolar Disorders, 2013, 15, 8
  14. 14
    Gustavo H. Vázquez, Leonardo Tondo, Juan Undurraga, Ross J. Baldessarini, Overview of antidepressant treatment of bipolar depression, The International Journal of Neuropsychopharmacology, 2013, 16, 07, 1673

    CrossRef

  15. 15
    Sabrina Paterniti, Jean-Claude Bisserbe, Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service, BMC Psychiatry, 2013, 13, 1, 211

    CrossRef

  16. 16
    Ya-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, Yi-Chyan Chen, Mei-Chun Hsiao, Cheng-Ta Li, Peichi Tu, Shang-Wen Chang, Winston W. Shen, Tung-Ping Su, Taiwan consensus of pharmacological treatment for bipolar disorder, Journal of the Chinese Medical Association, 2013, 76, 10, 547

    CrossRef

  17. 17
    Joseph M. Cerimele, Lydia A. Chwastiak, Ya-Fen Chan, David A. Harrison, Jürgen Unützer, The Presentation, Recognition and Management of Bipolar Depression in Primary Care, Journal of General Internal Medicine, 2013, 28, 12, 1648

    CrossRef

  18. 18
    Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder, The World Journal of Biological Psychiatry, 2013, 14, 3, 154

    CrossRef

  19. 19
    Laura Musetti, Claudia Del Grande, Donatella Marazziti, Liliana Dell'Osso, Treatment of bipolar depression, CNS Spectrums, 2013, 18, 04, 177

    CrossRef

  20. 20
    Michelle M. Sidor, Glenda M. MacQueen, An Update on Antidepressant Use in Bipolar Depression, Current Psychiatry Reports, 2012, 14, 6, 696

    CrossRef

  21. 21
    Laura S. Lorenzo, Gustavo H. Vázquez, Rodolfo M. Zaratiegui, Leonardo Tondo, Ross J. Baldessarini, Characteristics of bipolar disorder patients given antidepressants, Human Psychopharmacology: Clinical and Experimental, 2012, 27, 5
  22. 22
    Umberto Albert, Andrea Aguglia, Francesca Barbaro, David De Cori, Giuseppe Maina, Filippo Bogetto, Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti, Quaderni Italiani di Psichiatria, 2012, 31, 4, 190

    CrossRef

  23. 23
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  24. 24
    Rasmus W. Licht, Lithium: Still a Major Option in the Management of Bipolar Disorder, CNS Neuroscience & Therapeutics, 2012, 18, 3
  25. 25
    Peter Niemegeers, Kristof E Maudens, Manuel Morrens, Lisbeth Patteet, Leen Joos, Hugo Neels, Bernard GC Sabbe, Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 9, 1189

    CrossRef

  26. 26
    Michele Fornaro, Matteo Martino, Concetta De Pasquale, Driss Moussaoui, The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states?, Expert Opinion on Pharmacotherapy, 2012, 13, 14, 2037

    CrossRef

  27. 27
    J. Phelps, S. N. Ghaemi, The mistaken claim of bipolar ‘overdiagnosis’: solving the false positives problem for DSM-5/ICD-11, Acta Psychiatrica Scandinavica, 2012, 126, 6
  28. 28
    Mark A. Frye, Bipolar Disorder — A Focus on Depression, New England Journal of Medicine, 2011, 364, 1, 51

    CrossRef

  29. 29
    I. Pacchiarotti, M. Valentí, C.M. Bonnin, A.R. Rosa, A. Murru, G.D. Kotzalidis, A.M.A. Nivoli, J. Sánchez-Moreno, E. Vieta, F. Colom, Factors associated with initial treatment response with antidepressants in bipolar disorder, European Neuropsychopharmacology, 2011, 21, 5, 362

    CrossRef

  30. 30
    Andrea Aguglia, Umberto Albert, David De Cori, Giuseppe Maina, Filippo Bogetto, Il trattamento del disturbo ossessivo-compulsivo resistente, Quaderni Italiani di Psichiatria, 2011, 30, 1, 16

    CrossRef

  31. 31
    P. Courtet, L. Samalin, E. Olié, Les antidépresseurs dans le trouble bipolaire, L'Encéphale, 2011, 37, S196

    CrossRef

  32. 32
    Marc LM van der Loos, Paul Mulder, Erwin GThM Hartong, Marc BJ Blom, Anton C Vergouwen, Martijn S van Noorden, Manuela A Timmermans, Eduard Vieta, Willem A Nolen, Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design, Bipolar Disorders, 2011, 13, 1
  33. 33
    Alessandra M.A. Nivoli, Francesc Colom, Andrea Murru, Isabella Pacchiarotti, Piero Castro-Loli, Ana González-Pinto, Kostas N. Fountoulakis, Eduard Vieta, New treatment guidelines for acute bipolar depression: A systematic review, Journal of Affective Disorders, 2011, 129, 1-3, 14

    CrossRef

  34. You have free access to this content34
    Jared W Young, Brook L Henry, Mark A Geyer, Predictive animal models of mania: hits, misses and future directions, British Journal of Pharmacology, 2011, 164, 4
  35. 35
    Oscar Heeren, Manuel Sánchez De Carmona, Gustavo Vásquez, Rodrigo Córdoba, Jorge Forero, Luis Madrid, Diogo Lara, Rafael Medina, Luis Meza, Psychopharmacological treatment of bipolar disorder in Latin American, Revista de Psiquiatría y Salud Mental (English Edition), 2011, 4, 4, 205

    CrossRef

  36. 36
    Giovanni A. Fava, Emanuela Offidani, The mechanisms of tolerance in antidepressant action, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, 35, 7, 1593

    CrossRef

  37. 37
    Oscar Heeren, Manuel Sánchez De Carmona, Gustavo Vásquez, Rodrigo Córdoba, Jorge Forero, Luis Madrid, Diogo Lara, Rafael Medina, Luis Meza, Tratamiento psicofarmacológico del trastorno bipolar en América Latina, Revista de Psiquiatría y Salud Mental, 2011, 4, 4, 205

    CrossRef

  38. 38
    Antonio Tundo, Paola Cavalieri, Serena Navari, Fulvia Marchetti, Treating bipolar depression – antidepressants and alternatives: a critical review of the literature, Acta Neuropsychiatrica, 2011, 23, 3
  39. 39
    Kemal Dumlu, Zahide Orhon, Ayşegül Özerdem, Ümit Tural, Halis Ulaş, Zeliha Tunca, Treatment-induced manic switch in the course of unipolar depression can predict bipolarity: Cluster analysis based evidence, Journal of Affective Disorders, 2011, 134, 1-3, 91

    CrossRef

  40. 40
    L. Tondo, B. Lepri, N. Cruz, R. J. Baldessarini, Age at onset in 3014 Sardinian bipolar and major depressive disorder patients, Acta Psychiatrica Scandinavica, 2010, 121, 6
  41. 41
    H. Grunze, S. Dargel, Akut- und Langzeittherapie der bipolaren Depressionen, Der Nervenarzt, 2010, 81, 5, 539

    CrossRef

  42. 42
    Ross J. Baldessarini, Eduard Vieta, Joseph R. Calabrese, Mauricio Tohen, Charles L. Bowden, Bipolar Depression: Overview and Commentary, Harvard Review of Psychiatry, 2010, 18, 3, 143

    CrossRef

  43. 43
    Jay D. Amsterdam, Justine Shults, Efficacy and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy of Bipolar II Major Depressive Episode, Journal of Clinical Psychopharmacology, 2010, 30, 3, 306

    CrossRef

  44. 44
    Ross J Baldessarini, Paola Salvatore, Hari-Mandir Kaur Khalsa, Priscilla Gebre-Medhin, Harkaitz Imaz, Ana González-Pinto, Jesus Perez, Núria Cruz, Carlo Maggini, Mauricio Tohen, Morbidity in 303 first-episode bipolar I disorder patients, Bipolar Disorders, 2010, 12, 3
  45. 45
    Barbara Geller, Rebecca Tillman, Kristine Bolhofner, Betsy Zimerman, Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up, Bipolar Disorders, 2010, 12, 2
  46. 46
    Arash Ansari, David N. Osser, The Psychopharmacology Algorithm Project at the Harvard South Shore Program, Harvard Review of Psychiatry, 2010, 18, 1, 36

    CrossRef

  47. 47
    G. S. Malhi, D. Adams, L. Lampe, M. Paton, N. O’Connor, L. A. Newton, G. Walter, A. Taylor, R. Porter, R. T. Mulder, M. Berk, Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, 2009, 119,
  48. 48
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 3
  49. 49
    D. J. Smith, L. Forty, E. Russell, S. Caesar, J. Walters, C. Cooper, I. Jones, L. Jones, N. Craddock, Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome, Acta Psychiatrica Scandinavica, 2009, 119, 4
  50. 50
    Mark A. Frye, Giulio Perugi, Comorbidity in Bipolar Disorder: A Focus on Addiction and Anxiety Disorders,
  51. 51
    References,
  52. 52
    Boghos I. Yerevanian, The Role of Antidepressants in Bipolar Disorder,